Skip to search formSkip to main contentSkip to account menu

GS 4104

Known as: GS-4104, GS4104 
The acetate prodrug of GS 4071.
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oseltamivir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
CSHP Position Statement on Pharmacist as Head of Hospital Pharmacy
In our consideration of the role of the pharmacist as head of hospital pharmacy services, we have come to conclusions that differ… 
2001
2001
The Role of Neuraminidase Inhibitors in the Treatment and Prevention of Influenza.
The causative agents of acute respiratory infections in children and adults are mostly thought to be viruses. Many types of… 
2000
2000
Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice.
Review
2000
Review
2000
Antiviral therapy: current options and challenges.
This article reviews current options and concepts for drug treatment of viral infections with the exception of human… 
1999
1999
Influence of Treatment Schedule and Viral Challenge Dose on the in Vivo Influenza Virus-Inhibitory Effects of the Orally Administered Neuraminidase Inhibitor GS 4104
Experiments were done to determine how an alteration of the treatment schedule of 5 or 32 mg/kg/day per os (p.o.) doses of GS… 
1999
1999
Adjusting FDA policies to address bioterrorist threat
exchange, Gilead, Roche, BioCryst, and Johnson & Johnson appeared unaffected by the news. However, the companies seem reluctant… 
1998
1998
Biexponential Decomposition of a Neuraminidase Inhibitor Prodrug (GS-4104) in Aqueous Solution
AbstractPurpose. To examine the degradation kinetics and identify the degradation products of a neuraminidase inhibitor prodrug… 
1998
1998
[Influenza: new therapeutic perspectives].
UNLABELLED TWO WELL-KNOWN AGENTS: Although the activity of amantadin and rimantadin against type A Myxovirus influenzae are well… 
1998
1998
New Approaches to Influenza ChemotherapyInhibitors
Epidemic influenza continues to be associated with significant morbidity in the general population, and mortality in the elderly… 
1998
1998
GS-4104 Gilead Sciences Inc.
  • A. Billich
  • IDrugs : the investigational drugs journal
  • 1998
  • Corpus ID: 24487960
Gilead and Roche are codeveloping GS-4104, a neuraminidase inhibitor, for the potential treatment and prevention of influenza… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)